Skip to main content

Table 2 Aerob and microaerophil (LAB) bacterial fecal flora: log. numbers of characteristic bacteria at the three timepoints in the different groups. No statistically significant change between time points within and between groups.

From: Mediterranean diet or extended fasting's influence on changing the intestinal microflora, immunoglobulin A secretion and clinical outcome in patients with rheumatoid arthritis and fibromyalgia: an observational study

 

Baseline (n = 51)

Discharge (n = 47)

3 Months-FU (n = 43)

 

Mean ± SD

Median (IQR)

Mean ± SD

Median (IQR)

Mean ± SD

Median (IQR)

Escheria coli

      

   Fasting, RA.

6.8 ± 1.6

7.6 (6.0–7.9)

7.0 ± 1.6

7.9 (6.0–8.0)

6.1 ± 1.6

6.5 (5.0–7.5)

   Fasting, FM

6.7 ± 1.3

7.0 (6.0–8.0)

6.7 ± 1.4

7.0 (6.5–7.7)

6.2 ± 1.4

6.3 (5.2–7.0)

   MD, RA

5.6 ± 1.9

5.3 (3.7–7.7)

5.5 ± 2.1

4.8 (3.7–7.7)

6.3 ± 1.8

6.5 (5.3.–7.8)

   MD, FM

6.7 ± 1.6

7.5 (5.0–7.8)

6.4 ± 1.6

7.0 (5.0–7.6)

6.2 ± 0.8

6.0 (5.7–6.5)

Enterococcus

      

   Fasting, RA

6.6 ± 1.0

7.0 (6.0–7.3)

6.6 ± 1.3

7.0(5.3–8.0)

6.3 ± 0.7

6.0 (6.0–6.5)

   Fasting, FM

6.2 ± 1.1

6.0 (5.5–7.0)

5.6 ± 1.4

5.8(4.3–7.8)

5.9 ± 1.4

6.0 (5.2–7.2)

   MD, RA

5.7 ± 0.7

5.5 (5.0–6.0)

6.0 ± 1.3

6.0 (6.0–7.0)

5.7 ± 1.5

5.8 (5.5–6.0)

   MD, FM

5.9 ± 1.5

6.2 (5.0–7.0)

6.1 ± 1.5

6.1 (5.2–7.5)

5.8 ± 1.1

5.6 (5.3–6.3)

Lactobacillus (LAB)

      

   Fasting, RA

5.8 ± 0.5

6.0 (5.5–6.3)

5.2 ± 0.8

5.5(5.3–5.6)

5.1 ± 1.0

5.3 (4.3–6.0)

   Fasting, FM

5.4 ± 0.7

5.5 (5.3–6.0)

5.3 ± 0.9

5.5(4.7–6.0)

5.3 ± 1.1

5.7 (4.5–6.0)

   MD, RA

4.8 ± 0.6

5.0 (4.3–5.3)

5.1 ± 1.0

5.0 (5.0–6.0)

4.2 ± 0.9

4.0 (4.0–4.5)

   MD, FM

4.8 ± 1.2

5.0 (4.3–5.7)

5.7 ± 0.7

5.8 (5.5–6.0)

5.2 ± 0.9

5.3 (5.0–6.0)

  1. FU, follow-up; IQR, interquartile range; MD, Mediterranean diet; RA, rheumatoid arthritis; FM, fibromyalgia.